Cuifeng Xia

596 total citations
11 papers, 375 citations indexed

About

Cuifeng Xia is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Cuifeng Xia has authored 11 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Molecular Biology and 4 papers in Cancer Research. Recurrent topics in Cuifeng Xia's work include Colorectal Cancer Treatments and Studies (3 papers), MicroRNA in disease regulation (3 papers) and Colorectal and Anal Carcinomas (2 papers). Cuifeng Xia is often cited by papers focused on Colorectal Cancer Treatments and Studies (3 papers), MicroRNA in disease regulation (3 papers) and Colorectal and Anal Carcinomas (2 papers). Cuifeng Xia collaborates with scholars based in China and United States. Cuifeng Xia's co-authors include Xianshuo Cheng, Tao Shen, Zhibin Yang, Yunfeng Li, Xuan Zhang, Tao Wu, Qiang Li, Pin Gao, Xinyi Cai and Kun Yu and has published in prestigious journals such as Journal of Clinical Oncology, Frontiers in Immunology and Cancer Letters.

In The Last Decade

Cuifeng Xia

10 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cuifeng Xia China 7 178 155 151 75 59 11 375
Fuao Cao China 12 255 1.4× 125 0.8× 113 0.7× 61 0.8× 40 0.7× 30 381
Kaimi Li China 12 211 1.2× 138 0.9× 132 0.9× 79 1.1× 32 0.5× 15 397
Chun‐Hua Wang China 14 223 1.3× 126 0.8× 129 0.9× 72 1.0× 23 0.4× 20 413
Peifen Fu China 9 135 0.8× 214 1.4× 97 0.6× 93 1.2× 31 0.5× 19 390
Chenggong Sun China 14 223 1.3× 103 0.7× 163 1.1× 63 0.8× 32 0.5× 18 430
Tian‐En Li China 8 250 1.4× 116 0.7× 173 1.1× 81 1.1× 58 1.0× 9 451
Weiyuan Wei China 13 264 1.5× 133 0.9× 197 1.3× 26 0.3× 48 0.8× 19 413
Emanuela Minna Italy 9 230 1.3× 85 0.5× 152 1.0× 68 0.9× 29 0.5× 12 392
Areumnuri Kim South Korea 13 250 1.4× 160 1.0× 97 0.6× 33 0.4× 78 1.3× 22 404

Countries citing papers authored by Cuifeng Xia

Since Specialization
Citations

This map shows the geographic impact of Cuifeng Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cuifeng Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cuifeng Xia more than expected).

Fields of papers citing papers by Cuifeng Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cuifeng Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cuifeng Xia. The network helps show where Cuifeng Xia may publish in the future.

Co-authorship network of co-authors of Cuifeng Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Cuifeng Xia. A scholar is included among the top collaborators of Cuifeng Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cuifeng Xia. Cuifeng Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
2.
Zhang, Xuan, Qing Feng, Kun Yu, et al.. (2024). Preliminary efficacy and safety of total neoadjuvant therapy combined with PD-L1 blockade in pMMR/MSS locally advanced rectal cancer (ESTIMATE): A prospective, single-arm, phase II trial.. Journal of Clinical Oncology. 42(16_suppl). e15602–e15602. 1 indexed citations
3.
Shen, Qiushuo, Yanfei Han, Kai Wu, et al.. (2022). MrgprF acts as a tumor suppressor in cutaneous melanoma by restraining PI3K/Akt signaling. Signal Transduction and Targeted Therapy. 7(1). 147–147. 29 indexed citations
4.
Zhang, Xuan, Tao Wu, Cuifeng Xia, et al.. (2022). Neoadjuvant Immunotherapy for MSI-H/dMMR Locally Advanced Colorectal Cancer: New Strategies and Unveiled Opportunities. Frontiers in Immunology. 13. 795972–795972. 81 indexed citations
5.
6.
Liu, Baiyang, Wenjing Cheng, Jun Pu, et al.. (2021). PirB functions as an intrinsic suppressor in hippocampal neural stem cells. Aging. 13(12). 16062–16071. 5 indexed citations
7.
Xia, Cuifeng, Qiang Li, Xianshuo Cheng, Tao Wu, & Pin Gao. (2021). miR-4323 targets hepatoma-derived growth factor (HDGF) to suppress colorectal cancer cell proliferation. Pathology - Research and Practice. 225. 153544–153544. 5 indexed citations
8.
Shen, Tao, Xianshuo Cheng, Cuifeng Xia, et al.. (2019). Erlotinib inhibits colon cancer metastasis through inactivation of TrkB‐dependent ERK signaling pathway. Journal of Cellular Biochemistry. 120(7). 11248–11255. 13 indexed citations
9.
Shen, Tao, Xianshuo Cheng, Xin Liu, et al.. (2019). Circ_0026344 restrains metastasis of human colorectal cancer cells via miR-183. Artificial Cells Nanomedicine and Biotechnology. 47(1). 4038–4045. 59 indexed citations
10.
Shen, Tao, Zhibin Yang, Xianshuo Cheng, et al.. (2017). CXCL8 induces epithelial-mesenchymal transition in colon cancer cells via the PI3K/Akt/NF-κB signaling pathway. Oncology Reports. 37(4). 2095–2100. 63 indexed citations
11.
Yang, Zhibin, Xianshuo Cheng, Tao Shen, et al.. (2015). CXCL8, overexpressed in colorectal cancer, enhances the resistance of colorectal cancer cells to anoikis. Cancer Letters. 361(1). 22–32. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fuao Cao Breakdown of academic impact, for papers by Kaimi Li Breakdown of academic impact, for papers by Chun‐Hua Wang Breakdown of academic impact, for papers by Peifen Fu Breakdown of academic impact, for papers by Chenggong Sun Breakdown of academic impact, for papers by Tian‐En Li Breakdown of academic impact, for papers by Weiyuan Wei Breakdown of academic impact, for papers by Emanuela Minna Breakdown of academic impact, for papers by Areumnuri Kim
Rankless by CCL
2026